About MedSleuth

medsleuth.com

MedSleuth is transforming the way patients participate in their healthcare.

Revenue : 10M-50M Industry : Information Technology and Services Location : United States Employees : 1-10

SaaS Adoption

SaaS Adoption indicates the level of adoption by this company of software as a service services.

Cloud Adoption

Cloud Adoption indicates the level of adoption by this company of cloud services.

IT Footprint

IT Footprint gives a relative indication of how much IT services this company consumes.

IT Spend

IT Spend shows roughly how much this client spends on IT per year in USD.

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Know the products your prospects use

Enlyft provides you with access to our real-time data platform where you can access insights into a company’s tech stack, firmographic data, and more.

Vendor Usage

MedSleuth uses 5 different technologies from 19 different vendors. They have above average use of several technologies including Java, Python and Salesforce.com CRM.

Product Categories

MedSleuth uses products from 20 different product categories. They are particularly heavy users of products in Cloud Platforms & Services, Software Frameworks, and Programming Languages.

Recently Detected Technologies

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Technology Category Vendor Usage
Java Programming Languages Oracle
Python Programming Languages Python Software Foundation
Salesforce.com CRM Customer Relationship Management (CRM) Salesforce.com, inc
Sauce Labs Software Testing Tools Sauce Labs
Media Temple Web Hosting Services Media Temple

Are you interested in knowing other companies with similar tech stacks?

Reveal what vendors your prospects are using

Enlyft Sales Insights gives you instant access to the tech stack and firmographics of millions of companies worldwide.
Logos provided by Clearbit

© Enlyft | All rights reserved.